ARTICLE | Clinical News
Azilsartan medoxomil regulatory update
October 25, 2010 7:00 AM UTC
The European Medicines Agency accepted for review an MAA from Takeda for azilsartan medoxomil to treat hypertension. The angiotensin II type 1 (AT1) receptor blocker is also under FDA review. ...